Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.10.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.89ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.89ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.89NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HP.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HP.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HP.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
GW.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GW.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
GS.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCF.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCF.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
HY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
XBB.1.5.105ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.105ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.105ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.105NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.9.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.9.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
GJ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used